心肌T1 mapping及细胞外容积定量作为系统性硬化症患者风险分层的新型生物标志物
研究33例系统性硬化症(SSc)患者与33例年龄性别匹配健康对照,采用心血管磁共振(CMR)多参数成像包括原生T1 mapping、细胞外容积(ECV)计算、T2 mapping及晚期钆增强(LGE),随访心脏死亡、血流动力学显著心律失常或心力衰竭。SSc患者原生T1、T2及ECV均高于对照,LGE、原生T1及ECV与随访不良事件显著相关,原生T1≥1,069 ms或ECV≥31.4%者生存曲线显著分离。结论认为心肌受累在SSc中常见,原生T1 mapping与ECV是心肌纤维化的新型无创标志物,可用于SSc患者风险分层。
要点
- SSc患者心肌原生T1、T2及ECV均显著高于健康对照,提示心肌受累常见。
- 原生T1≥1,069 ms或ECV≥31.4%时,Kaplan-Meier生存曲线显著分离。
- LGE、原生T1及ECV在多变量Cox回归中与随访不良事件显著相关。
关键影像表现/征象
- SSc患者心肌原生T1为1,058.9±71 ms,高于对照的989.4±21.4 ms(p<0.001)。
- SSc患者T2为54.9±5.7 ms,高于对照的50±2.5 ms(p<0.001)。
- SSc患者ECV为27.9±5.4%,高于对照的24.8±2%(p<0.004)。
- 8例(24%)患者存在LGE,其中2例心内膜下、5例壁内、4例心外膜下。
诊断标准与关键数值
- 原生T1升高阈值≥1,069 ms时,Kaplan-Meier生存曲线显著分离。
- ECV升高阈值≥31.4%时,Kaplan-Meier生存曲线显著分离。
- LGE、原生T1及ECV在多变量Cox回归中与随访不良事件显著相关。
临床应用与阅片要点
- 在SSc患者CMR检查中可关注原生T1 mapping与ECV定量,并结合LGE评估心肌纤维化。
- 原生T1≥1,069 ms或ECV≥31.4%提示不良事件风险较高,可作为风险分层参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To study the prognostic value of myocardial native T1 and extracellular volume (ECV), measured by cardiovascular magnetic resonance (CMR), in patients with systemic sclerosis (SSc).
MATERIALS AND METHODS: Thirty-three SSc patients (16/33 male, 48.5%) were studied using multiparametric CMR including native T1 mapping with ECV calculation, T2 mapping, and late gadolinium enhancement (LGE). Patients were followed-up for cardiac death, haemodynamically significant arrhythmia, or heart failure. Results were compared with 33 age- and gender-matched healthy controls.
RESULTS: When compared with controls, SSc patients had higher myocardial native T1 (1,058.9±71 versus 989.4±21.4 ms, p<0.001), higher T2 (54.9±5.7 versus 50±2.5 ms, p<0.001), and ECV values (27.9±5.4% versus 24.8±2%, p<0.004). LGE was present in eight patients (24%), two subendocardial, five midwall, and four subepicardial. LGE, native T1, and ECV were significantly associated with adverse events during follow-up in multivariate Cox regression analysis. Kaplan-Meier analysis demonstrated significant divergence of the survival curves based on the presence of elevated native T1 (≥1,069 ms) or ECV (≥31.4%) values.
CONCLUSION: Cardiac involvement is frequent in SSc. Both native T1 mapping and ECV represent novel non-invasive markers of myocardial fibrosis and could be used in the risk stratification of patients with SSc. CMR mapping may provide a novel biomarker for disease monitoring and study of therapies aiming to reduce myocardial fibrosis in SSc.
引用
- Bordonaro V, Bivort D, Dresselaers T, et al. Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis. Clin Radiol. 2020. PMID: 33109349. doi:10.1016/j.crad.2020.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。